Form 4: Castle Biosciences COO Kristen Oelschlager Reports Stock Transactions
SEC Form 4 Filing
Kristen Oelschlager, COO of Castle Biosciences, reports acquisition and disposal of common stock and restricted stock units.
Summary
- On March 4, 2025, Kristen Oelschlager, the Chief Operating Officer of Castle Biosciences, reported transactions involving the company's stock.
- Oelschlager acquired 13,811 shares of common stock through the vesting of restricted stock units (RSUs).
- She also disposed of 3,640 shares to cover tax obligations at a price of $22.23 per share.
- Following these transactions, Oelschlager directly owns 163,964 shares of common stock.
- Additionally, she holds 47,838 restricted stock units, which vest in four equal annual installments beginning on March 4, 2026.
- The reported transactions also include 1,271 shares acquired on February 28, 2025, under the Issuer's employee stock purchase plan.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it is a standard regulatory filing reporting stock transactions by an insider. There is no inherent positive or negative implication.
Future Outlook
The document does not contain any specific forward-looking statements or guidance.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC when company insiders, like the COO, trade their company's stock. It provides transparency to the market regarding the transactions of company leadership.
Stakeholder Impact
- The transactions may have a minor impact on shareholders by slightly increasing the float of available shares.
Key Dates
| Date | Description |
|---|---|
| 03/04/2025 | Date of earliest transaction (acquisition and disposal of shares and RSUs) |
| 02/28/2025 | Date of acquisition of shares under the employee stock purchase plan |
| 03/04/2026 | First vesting date of the 47,838 RSUs |
| 03/06/2025 | Date of signature for the Form 4 filing |
Keywords
Form 4, insider trading, CSTL, Castle Biosciences, Oelschlager, stock transaction, restricted stock units, COO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.